Consumer group Community Catalyst announced its second annual Bitter Pill Awards, skewering the makers of Ambien, Lunesta and Strattera, among others, for what it deems to be irresponsible marketing practices.
For marketers, talking with colleagues in R&D is key to optimal product positioning and in-sync messaging. Marc Iskowitz looks at how early collaboration between the two camps can pay off
Blogs are legion. Pharmaceuticals are a favorite topic of many, and a few are highly influential with patients and the press. How should companies engage this medium? Read, reach out or join them?
How Will Patients Behave?
June 1, 2006
6:33 pm
A study of consumer preferences for seeking and using information
The once-exploding ADHD market has been tempered of late. And as drug firms continue to battle bad press and tough regulations, a pipeline challenge looms: how to match the efficacy of the big-name stimulants.
With the direct-to-patient movement well underway, pharmaceutical marketers are getting savvier at striking a chord with their patients in the quest for compliance.